References
- Couser WG. Primary membranous nephropathy. Clin J Am Soc Nephrol. 2017;12(6):983–997. doi:10.2215/CJN.11761116
- Ronco P, Beck L, Debiec H, et al.. Membranous nephropathy. Nat Rev Dis Primers. 2021;7(1):69.
- Beck LH Jr, Bonegio RG, Lambeau G, et al.. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21. doi:10.1056/NEJMoa0810457
- Safar-Boueri L, Piya A, Beck LH Jr, Ayalon R. Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era. Pediatr Nephrol. 2021;36(1):19–30. doi:10.1007/s00467-019-04425-1
- Burbelo PD, Joshi M, Chaturvedi A, et al.. Detection of PLA2R autoantibodies before the diagnosis of membranous nephropathy. J Am Soc Nephrol. 2020;31(1):208–217. doi:10.1681/ASN.2019050538
- Stefan G, Stancu S, Zugravu A, et al.. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy. Ren Fail. 2022;44(1):258–268. doi:10.1080/0886022X.2022.2033265
- Xu NX, Xie QH, Sun ZX, et al.. renal phospholipase A2 receptor and the clinical features of idiopathic membranous nephropathy. Chin Med J. 2017;130(8):892–898. doi:10.4103/0366-6999.204096
- Zhang QH, Wu M, Hu ZG, et al.. Serum antibody and glomerular antigen of antiphospholipase A2 receptor in Chinese patients with idiopathic membranous nephropathy. Biomed Res Int. 2020;2020:1693710. doi:10.1155/2020/1693710
- Xie Z, Dong W, Li Z, et al.. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: a retrospective cohort study. Nephrology . 2020;25(3):219–229. doi:10.1111/nep.13691
- Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):753–779. doi:10.1016/j.kint.2021.05.015
- Li JN. Diagnosis of Idiopathic Membranous Nephropathy in Patients with Serum Anti-M Type phospholipase A2 Receptor (PLA2R) Antibody Negative . Peking Union Medical College; 2015.
- Hou X, Xu M, Liu YY. Diagnostic value of serum PLA2R antibody and renal PLA2R detection in idiopathic membranous nephropathy. J Pract Med. 2020;37(10):901–902.
- Cui J, Li WN, Lou JQ, Qi D, Zhang Y. Expression of M-type phospholipase A2 receptor and Nephrin in renal tissue of patients with idiopathic membranous nephropathy and its influence on prognosis. J Clin Exp Pathol. 2015;31(03):333–335.
- Liu H, Luo W, Gong S, Ding X. Detection and clinical significance of glomerular M-type phospholipase A2 receptor in patients with idiopathic membranous nephropathy. Intern Med J. 2016;46(11):1318–1322. doi:10.1111/imj.13233
- Zhang D, Zou J, Zhang C, Zhang W, Lin F, Jiang G. Clinical and histological features of phospholipase A2 receptor-associated and thrombospondin Type-I domain-containing 7A-associated idiopathic membranous nephropathy: a Single Center Retrospective Study from China. Med Sci Monit. 2018;24:5076–5083. doi:10.12659/MSM.909815